Verismo Therapeutics
Pre-clinicalA paradigm-shifting technology featuring KIR-based CAR construct that has been proven to reduce T cell exhaustion & kill solid tumor models in in vivo studies.
Founded
2018
Focus
Cell & Gene Therapy
About
A paradigm-shifting technology featuring KIR-based CAR construct that has been proven to reduce T cell exhaustion & kill solid tumor models in in vivo studies.
Funding History
2Total raised: $30M
Series A$25MHealthCapMay 15, 2022
Seed$5MUniversity of PennsylvaniaSep 15, 2020
Company Info
TypePrivate
Founded2018
LocationPhiladelphia, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile